Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
Microsoft
MSFT
|
+$112M |
| 2 |
Ferguson
FERG
|
+$104M |
| 3 |
Amazon
AMZN
|
+$101M |
| 4 |
Apple
AAPL
|
+$98.3M |
| 5 |
International Flavors & Fragrances
IFF
|
+$75M |
Top Sells
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$52.5M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$38.1M |
| 5 |
Equity Residential
EQR
|
+$22.8M |
Sector Composition
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.72% |
| 4 | Communication Services | 10.9% |
| 5 | Industrials | 9.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1126
Applied Industrial Technologies
AIT
$9.94B
| $8.08M | 0.01% |
88,600
+900
| +1% | +$82.1K |
|
1127
Diodes
DIOD
$2.44B
| $8.07M | 0.01% |
101,100
+1,500
| +2% | +$120K |
|
1128
Blackbaud
BLKB
$3.38B
| $8.05M | 0.01% |
113,253
+1,200
| +1% | +$85.3K |
|
1129
Rogers Corp
ROG
$1.47B
| $8.04M | 0.01% |
42,700
+400
| +0.9% | +$75.3K |
|
1130
Hain Celestial
HAIN
$194M
| $8.04M | 0.01% |
184,314
| – | – |
|
1131
Dana Inc
DAN
$2.76B
| $8.03M | 0.01% |
330,200
+2,700
| +0.8% | +$65.7K |
|
1132
SPS Commerce
SPSC
$4B
| $8.01M | 0.01% |
80,700
+1,300
| +2% | +$129K |
|
1133
Veracyte
VCYT
$2.43B
| $8.01M | 0.01% |
149,100
+20,900
| +16% | +$1.12M |
|
|
STAY
1134
DELISTED
Extended Stay America, Inc. Paired Share Unit
STAY
| $8.01M | 0.01% |
405,686
+3,400
| +0.8% | +$67.1K |
|
1135
Credit Acceptance
CACC
$5.33B
| $7.99M | 0.01% |
22,177
+200
| +0.9% | +$72K |
|
1136
Allete
ALE
$3.67B
| $7.98M | 0.01% |
118,800
+1,400
| +1% | +$94.1K |
|
1137
FormFactor
FORM
$2.32B
| $7.98M | 0.01% |
176,800
+2,600
| +1% | +$117K |
|
|
ISBC
1138
DELISTED
Investors Bancorp, Inc.
ISBC
| $7.97M | 0.01% |
542,476
+5,700
| +1% | +$83.7K |
|
|
BHVN
1139
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
| $7.96M | 0.01% |
116,500
+1,800
| +2% | +$123K |
|
1140
Iovance Biotherapeutics
IOVA
$821M
| $7.96M | 0.01% |
251,356
+3,000
| +1% | +$95K |
|
1141
Ambarella
AMBA
$3.43B
| $7.94M | 0.01% |
79,133
+1,300
| +2% | +$131K |
|
1142
EPR Properties
EPR
$4.45B
| $7.94M | 0.01% |
170,488
+1,800
| +1% | +$83.9K |
|
1143
Qualys
QLYS
$4.82B
| $7.94M | 0.01% |
75,800
+400
| +0.5% | +$41.9K |
|
1144
Cardlytics
CDLX
$59.6M
| $7.93M | 0.01% |
72,300
+16,800
| +30% | +$1.84M |
|
1145
Insmed
INSM
$30.8B
| $7.93M | 0.01% |
232,700
+3,300
| +1% | +$112K |
|
1146
Ormat Technologies
ORA
$5.53B
| $7.93M | 0.01% |
100,934
+8,400
| +9% | +$660K |
|
1147
AMN Healthcare
AMN
$699M
| $7.92M | 0.01% |
107,500
+1,300
| +1% | +$95.8K |
|
1148
Ameris Bancorp
ABCB
$5.1B
| $7.92M | 0.01% |
150,744
+1,200
| +0.8% | +$63K |
|
1149
Meritage Homes
MTH
$5.61B
| $7.91M | 0.01% |
172,000
+1,800
| +1% | +$82.7K |
|
1150
LiveRamp
RAMP
$1.73B
| $7.86M | 0.01% |
151,500
+2,600
| +2% | +$135K |
|